Related by context. Frequent words. (Click for all words.) 64 therapeutic monoclonal antibodies 64 Inc Therapeutic Competitors 64 recombinant vaccines 64 Idera Pharmaceuticals 63 Vaccinex 63 Initiates Phase II 63 novel antibody therapeutics 63 NASDAQ CRXL 63 Regado Biosciences 63 Nasdaq MATK 62 bio therapeutics 62 Regulus Therapeutics 62 Hybridon 62 immunotherapeutics 62 Epitomics 62 MultiCell Technologies 62 Stemgent 61 oncolytic viruses 61 Fluidigm Corporation 61 Archemix Corp. 61 optical biosensors 61 developing Zerenex TM 61 microRNA therapeutics 61 Inc. Nasdaq SUPG 61 PolyTherics 61 Nasdaq CRXL 61 Presents Positive 61 DiscoveRx 60 FoldRx 60 novel RNAi therapeutics 60 Inc. NASDAQ MBLX 60 Codon Devices 60 Agios Pharmaceuticals 60 GlycosBio 60 Inc. Nasdaq IMGN 60 Chemokine Therapeutics 60 Emisphere Technologies 60 Receives Orphan Drug Designation 60 CureDM 60 taste modulators 60 ViaCyte 60 Nautilus Biotech 60 Silence Therapeutics plc 60 Mersana 60 specific ZFP Nucleases 60 commercial bioproduction 60 NASDAQ OSIR 60 HCV protease inhibitor 60 Argatroban 60 AltheaDx 60 addressing idiopathic pulmonary 60 exon skipping 60 Galenea 60 Inc. Nasdaq NEXM 60 Taligen 60 Adnexus Therapeutics 60 inflammatory autoimmune diseases 60 Takeda Kyowa Hakko Kirin 60 Diatos 59 Scancell 59 GVAX cancer 59 theranostic 59 Cerus Corporation 59 Sangamo ZFP technology 59 Metabasis Therapeutics Inc. 59 HepaLife Technologies Inc. 59 Elusys 59 ACLARA 59 OncoMed 59 iPSC technology 59 Aegera 59 aTyr Pharma 59 Sirona Biochem 59 Molecular Biometrics 59 humanized antibodies 59 Pressure BioSciences 59 Roche SIX RO 59 liposomal formulation 59 Medizone International Inc. 59 GVAX R 59 CardioVascular BioTherapeutics Inc. 59 Aradigm Corporation 59 ProtoKinetix Inc. 59 TLR9 agonists 59 Genaera Corporation 58 Ibis T# 58 commercializing therapeutic 58 polymeric formulations 58 Euroscreen 58 OMRIX 58 immuno inflammatory diseases 58 GRNVAC1 58 Exploit collaboration 58 topical anti infective 58 HepaLife 58 siRNA therapeutics 58 peptide synthesis 58 Eurogentec 58 Inovio Pharmaceuticals 58 Nasdaq ENMD 58 Kuvan R